Overview: Free Triiodothyronine TestIntroduction: The Free Triiodothyronine Test measures free T3 to diagnose thyroid disorders, causing heart palpitations. Aligned with 2023 ATA guidelines, it uses biochemical methods for high specificity, supporting hormonal screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in endocrinology for patients with suspected thyroid disorders.
Other Names: Free T3 Assay, Unbound T3 Test.
FDA Status: Laboratory-developed test (LDT), meeting endocrinology standards for diagnostic accuracy.
Historical Milestone: Free T3 testing began in the 1980s with thyroid research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures free T3 to diagnose thyroid disorders, guides treatment, and evaluates patients with heart palpitations.
Test Parameters: 1. Free T3 Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum or plasma. Report history of heart palpitations or thyroid symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document heart palpitations, weight changes, or history of thyroid disorders. Include current medications, especially thyroid medications.
Consent: Written consent required, detailing the tests purpose, thyroid disorder implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) or chemiluminescence to measure free T3 levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for thyroid disorder diagnosis.
Factors Affecting Result Accuracy: Improper fasting or sample hemolysis can affect results. Medications like amiodarone may alter T3 levels.
Clinical Significance: Abnormal free T3 confirms thyroid disorders, guiding thyroid hormone therapy. Normal levels may require TSH or T4 testing.
Specialist Consultation: Consult an endocrinologist for result interpretation and treatment planning.
Additional Supporting Tests: TSH, free T4, or thyroid ultrasound to confirm thyroid disorder diagnosis.
Test Limitations: Non-specific for certain thyroid conditions; clinical correlation is needed. Sample quality affects sensitivity.
References: ATA Thyroid Guidelines, 2023; Journal of Clinical Endocrinology, Jonklaas J, 2022.
